Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamal K Solanki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The New Zealand Medical Journal|April 27, 2004
Therapeutic challenges in goutKamal K Solanki, Peter Moller
Rheumatology and Immunology Research|December 5, 2022
The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis CohortCherumi Silva, Kamal K Solanki, Douglas H N White
International Journal of Rheumatic Diseases|July 4, 2018
Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosisSujatha Kamalaksha, Douglas H N White, Kamal K Solanki
The New Zealand Medical Journal|September 23, 2016
Rare coexistence of dermatomyositis and smooth muscle antibodies, with abnormal liver function testsVicki A Quincey, Kamal K Solanki, Duncan Lamont, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 24, 2018
High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic SclerosisKamal K Solanki, Mahmood Al-Majmuei, Douglas H N White
International Journal of Rheumatic Diseases|March 22, 2021
Increased malignancies in our Waikato cohort of patients with systemic sclerosisMonique S Rees, Chris Frampton, Douglas H N White, et al.
International Journal of Rheumatic Diseases|December 27, 2021
Correspondence reply to authors J A Vondenberg et: RE: Increased malignancies in systemic sclerosis (IJRD: IJRD-2021-0787)Monique S Rees, Chris Frampton, Douglas H N White, et al.
Clinical Rheumatology|May 30, 2015
A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New ZealandWinston S J Chang, Joanna Schollum, Douglas H N White, et al.
International Journal of Rheumatic Diseases|March 7, 2017
Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosisKamal K Solanki, Cecil Hor, Winston S J Chang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The New Zealand Medical Journal|April 27, 2004
Therapeutic challenges in goutKamal K Solanki, Peter Moller
Rheumatology and Immunology Research|December 5, 2022
The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis CohortCherumi Silva, Kamal K Solanki, Douglas H N White
International Journal of Rheumatic Diseases|July 4, 2018
Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosisSujatha Kamalaksha, Douglas H N White, Kamal K Solanki
The New Zealand Medical Journal|September 23, 2016
Rare coexistence of dermatomyositis and smooth muscle antibodies, with abnormal liver function testsVicki A Quincey, Kamal K Solanki, Duncan Lamont, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 24, 2018
High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic SclerosisKamal K Solanki, Mahmood Al-Majmuei, Douglas H N White
International Journal of Rheumatic Diseases|March 22, 2021
Increased malignancies in our Waikato cohort of patients with systemic sclerosisMonique S Rees, Chris Frampton, Douglas H N White, et al.
International Journal of Rheumatic Diseases|December 27, 2021
Correspondence reply to authors J A Vondenberg et: RE: Increased malignancies in systemic sclerosis (IJRD: IJRD-2021-0787)Monique S Rees, Chris Frampton, Douglas H N White, et al.
Clinical Rheumatology|May 30, 2015
A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New ZealandWinston S J Chang, Joanna Schollum, Douglas H N White, et al.
International Journal of Rheumatic Diseases|March 7, 2017
Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosisKamal K Solanki, Cecil Hor, Winston S J Chang, et al.
Pageof 1